Bioasis Technologies (FRA:107) Change In Receivables : €0.04 Mil (TTM As of Nov. 2022)

View and export this data going back to 2017. Start your Free Trial

What is Bioasis Technologies Change In Receivables?

Bioasis Technologies's change in receivables for the quarter that ended in Nov. 2022 was €0.00 Mil. It means Bioasis Technologies's Accounts Receivable declined by €0.00 Mil from Aug. 2022 to Nov. 2022 .

Bioasis Technologies's change in receivables for the fiscal year that ended in Feb. 2022 was €-0.05 Mil. It means Bioasis Technologies's Accounts Receivable increased by €0.05 Mil from Feb. 2021 to Feb. 2022 .

Bioasis Technologies's Accounts Receivable for the quarter that ended in Nov. 2022 was €0.01 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Bioasis Technologies's Days Sales Outstanding for the three months ended in Nov. 2022 was 8.37.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Bioasis Technologies's liquidation value for the three months ended in Nov. 2022 was €-3.13 Mil.

Bioasis Technologies Change In Receivables Historical Data

The historical data trend for Bioasis Technologies's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioasis Technologies Change In Receivables Chart

Bioasis Technologies Annual Data

Trend

Feb13

Feb14

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Change In Receivables

Get a 7-Day Free Trial

0.02

-0.01

-0.05

Bioasis Technologies Quarterly Data
	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22
Change In Receivables	Get a 7-Day Free Trial															-0.01	-0.03	-0.06	0.12	-

Bioasis Technologies Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Nov. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.04 Mil.

Bioasis Technologies (FRA:107) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Bioasis Technologies's Days Sales Outstanding for the quarter that ended in Nov. 2022 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.01	/	0.109	*	91
=	8.37

2. In Ben Graham's calculation of liquidation value, Bioasis Technologies's accounts receivable are only considered to be worth 75% of book value:

Bioasis Technologies's liquidation value for the quarter that ended in Nov. 2022 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.114	-	3.251	+	0.75 * 0.01	+	0.5 * 0
=	-3.13

Bioasis Technologies Change In Receivables Related Terms

Thank you for viewing the detailed overview of Bioasis Technologies's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioasis Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioasis Technologies Inc (FRA:107) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

157 Church Street, 19th Floor, New Haven, CT, USA, 06510

Website

https://www.bioasis.us

Bioasis Technologies Inc is a development stage biopharmaceutical company. It is engaged in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. The company has worked on a blood-brain barrier program and studies disorders in the brain. The company's xB3 program describes its proprietary carrier, for the delivery of therapeutics across the blood-brain barrier and the treatment of CNS disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases. The company's in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.

Bioasis Technologies Headlines

No Headlines